FBXO32 and Charcot-Marie-Tooth disease: Finally, ACE-083 treatment in CMT mice reduced intramuscular levels of Fbxo32 mRNA (encoding atrogin-1/MAFbx), an ubiquitin ligase that mediates muscle atrophy36, compared to the contralateral TA muscle (Fig. 4h).